Novel blood sugar biosensors to bring medical revolution

Published: 2007-08-16 07:00:00

Updated: 2007-08-16 07:00:00

"New biosensor technology for monitoring glucose levels in people with diabetes is moving ahead rapidly as a growing number of Korean biopharmaceutical companies are struggling to develop tailored systems of combining inexpensive biosensors with chips, according to the Korean Intellectual Propert...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK